placeholder image
JC Nelson All authors
About
Publications While At Healthpartners
selected publications
Journal Article
  • A broad assessment of covid-19 vaccine safety using tree-based data-mining in the vaccine safety datalink. 
    Vaccine. 2023
  • Active postlicensure safety surveillance for recombinant zoster vaccine using electronic health record data. 
    American Journal of Epidemiology. 2023
  • COVID-19 booster vaccination in early pregnancy and surveillance for spontaneous abortion. 
    JAMA network open. 2023
  • COVID-19 vaccine safety surveillance in early pregnancy in the United States: design factors affecting the association between vaccine and spontaneous abortion. 
    American Journal of Epidemiology. 2023
  • Medically attended acute adverse events in pregnant people after coronavirus disease 2019 (COVID-19) booster vaccination. 
    Obstetrics and Gynecology. 2023
  • Racial and ethnic disparities in influenza vaccination coverage among pregnant women in the United States: the contribution of vaccine-related attitudes. 
    Preventive Medicine. 2023
  • Safety signal identification for COVID-19 bivalent booster vaccination using tree-based scan statistics in the Vaccine Safety Datalink. 
    Vaccine. 2023
  • Tree-based data mining for safety assessment of first COVID-19 booster doses in the Vaccine Safety Datalink. 
    Vaccine. 2023
  • Changes in incidence rates of outcomes of interest in vaccine safety studies during the COVID-19 pandemic. 
    Vaccine. 2022
  • Evaluation of acute adverse events after Covid-19 vaccination during pregnancy. 
    New England Journal of Medicine. 2022
  • Health care utilization in the 6 months following SARS-CoV-2 infection. 
    JAMA network open. 2022
  • Incidence of Guillain-Barré syndrome after COVID-19 vaccination in the Vaccine Safety Datalink. 
    JAMA network open. 2022
  • Kawasaki disease following the 13-valent pneumococcal conjugate vaccine and rotavirus vaccines. 
    Pediatrics. 2022
  • Risk of myocarditis and pericarditis following BNT162b2 and mRNA-1273 COVID-19 vaccination. 
    Vaccine. 2022
  • Safety of COVID-19 vaccination in United States children ages 5 to 11 years. 
    Pediatrics. 2022
  • COVID-19 vaccination coverage among insured persons aged ≥16 years, by race/ethnicity and other selected characteristics - eight integrated health care organizations, United States, December 14, 2020-May 15, 2021. 
    MMWR: Morbidity and Mortality Weekly Report. 2021
  • COVID-19 vaccination coverage among pregnant women during pregnancy - eight integrated health care organizations, United States, December 14, 2020-May 8, 2021. 
    MMWR: Morbidity and Mortality Weekly Report. 2021
  • Surveillance for adverse events after COVID-19 mRNA vaccination. 
    JAMA. 2021
  • Challenges involved in establishing a web-based clinical decision support tool in community health centers. 
    Healthcare (Amsterdam, Netherlands). 2020
  • Evaluating the association of stillbirths after maternal vaccination in the Vaccine Safety Datalink. 
    Obstetrics and Gynecology. 2020
  • Safety of repeated doses of tetanus toxoid, reduced diphtheria toxoid, and acellular pertussis vaccine in adults and adolescents. 
    Pharmacoepidemiology and Drug Safety. 2018
  • Safety of measles-containing vaccines in 1-year-old children. 
    Pediatrics. 2015
  • Safety of diphtheria, tetanus, acellular pertussis and inactivated poliovirus (DTaP-IPV) vaccine. 
    Vaccine. 2014
  • Timely versus delayed early childhood vaccination and seizures. 
    Pediatrics. 2014
  • A population-based cohort study of undervaccination in 8 managed care organizations across the United States. 
    JAMA pediatrics. 2013
  • Association between undervaccination with diphtheria, tetanus toxoids, and acellular pertussis (DTaP) vaccine and risk of pertussis infection in children 3 to 36 months of age. 
    JAMA pediatrics. 2013
  • Vaccination site and risk of local reactions in children 1 through 6 years of age. 
    Pediatrics. 2013
  • Injection site and risk of medically attended local reactions to acellular pertussis vaccine. 
    Pediatrics. 2011
  • Frequency of medically attended adverse events following tetanus and diphtheria toxoid vaccine in adolescents and young adults: a Vaccine Safety Datalink study. 
    BMC Infectious Diseases. 2009
  • Frequency of medically attended adverse events following tetanus and diphtheria toxoid vaccine in adolescents and young adults: a Vaccine Safety Datalink study BMC Infect Dis
    2009
  • Risk of medically attended local reactions following diphtheria toxoid containing vaccines in adolescents and young adults: a Vaccine Safety Datalink study. 
    Vaccine. 2009
  • Risk of medically attended local reactions following diphtheria toxoid containing vaccines in adolescents and young adults: a Vaccine Safety Datalink study Vaccine
    2009
    • Contact
    full name
  • JC Nelson
  • J. C. Nelson
    • Quick Info
     
    Collaboration